OAM
COGT icon

Oxford Asset Management’s Cogent Biosciences COGT Stock Holding History

Oxford Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,931
Closed -$114K – 494
2025
Q2 		$114K Buy
+15,931
New +$88.3K 0.04% 474
2024
Q2 		– Sell
-15,808
Closed -$106K – 309
2024
Q1 		$106K Buy
+15,808
New +$97.7K 0.11% 225
2019
Q4 		– Sell
-25,000
Closed -$144K – 1787
2019
Q3 		$144K Buy
25,000
+17,334
+226% +$141K ﹤0.01% 1607
2019
Q2 		$80K Buy
+7,666
New +$102K ﹤0.01% 1622

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Oxford Asset Management's COGT Position: Q3 2025 in Review

Oxford Asset Management sold out of Cogent Biosciences (COGT) in Q3 2025, closing a stake of 15,931 shares — an estimated $114K sold.

Oxford Asset Management first reported a position in COGT in Q2 2019 and held it in 4 quarters. The position peaked at $144K in Q3 2019. 195 funds tracked by Wall St. Rank hold COGT as of Q3 2025.

  • Oxford Asset Management reported no remaining Cogent Biosciences position as of Q3 2025 after selling out during the quarter.
  • Oxford Asset Management sold 15,931 Cogent Biosciences shares in Q3 2025, an estimated $114K.
  • Oxford Asset Management first reported a position in Cogent Biosciences in Q2 2019 and held it in 4 quarters.
  • Oxford Asset Management's Cogent Biosciences position peaked at $144K in Q3 2019.
  • 195 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.